Caitrin Crudden

531 total citations
17 papers, 419 citations indexed

About

Caitrin Crudden is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Caitrin Crudden has authored 17 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Caitrin Crudden's work include Receptor Mechanisms and Signaling (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Extracellular vesicles in disease (4 papers). Caitrin Crudden is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Extracellular vesicles in disease (4 papers). Caitrin Crudden collaborates with scholars based in Sweden, Netherlands and United States. Caitrin Crudden's co-authors include Leonard Girnita, Ada Girnita, D. Michiel Pegtel, Maarten P. Bebelman, Claire Worrall, Dawei Song, Martine J. Smit, Shin‐Ichiro Takahashi, Eric Trocmé and Andrei Adrian Tica and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Caitrin Crudden

16 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caitrin Crudden Sweden 12 324 124 83 77 39 17 419
Claire Worrall Sweden 12 339 1.0× 94 0.8× 94 1.1× 144 1.9× 28 0.7× 17 513
Cristina T. Kesler United States 12 350 1.1× 92 0.7× 121 1.5× 90 1.2× 44 1.1× 13 563
Huiyuan Zheng Sweden 10 234 0.7× 73 0.6× 58 0.7× 58 0.8× 33 0.8× 18 405
Daiana Vasilcanu Sweden 10 357 1.1× 107 0.9× 77 0.9× 214 2.8× 17 0.4× 12 493
Eric Trocmé Sweden 8 214 0.7× 63 0.5× 123 1.5× 90 1.2× 101 2.6× 9 427
Radu Vasilcanu Sweden 9 498 1.5× 138 1.1× 96 1.2× 245 3.2× 20 0.5× 9 622
Romina Nejad Canada 10 226 0.7× 197 1.6× 63 0.8× 59 0.8× 14 0.4× 19 468
Bert Cruys Belgium 8 324 1.0× 230 1.9× 58 0.7× 15 0.2× 52 1.3× 10 533
Saar Vandekeere Belgium 3 282 0.9× 204 1.6× 37 0.4× 14 0.2× 46 1.2× 4 465
Kristen D. Hadfield United Kingdom 8 232 0.7× 105 0.8× 117 1.4× 25 0.3× 15 0.4× 11 514

Countries citing papers authored by Caitrin Crudden

Since Specialization
Citations

This map shows the geographic impact of Caitrin Crudden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caitrin Crudden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caitrin Crudden more than expected).

Fields of papers citing papers by Caitrin Crudden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caitrin Crudden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caitrin Crudden. The network helps show where Caitrin Crudden may publish in the future.

Co-authorship network of co-authors of Caitrin Crudden

This figure shows the co-authorship network connecting the top 25 collaborators of Caitrin Crudden. A scholar is included among the top collaborators of Caitrin Crudden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caitrin Crudden. Caitrin Crudden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Crudden, Caitrin, Jan Paul Bebelman, Noureldine Youssef, et al.. (2025). Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies. Nature Communications. 16(1). 10828–10828.
2.
Pegtel, D. Michiel, et al.. (2024). G protein-coupled receptors: a gateway to targeting oncogenic EVs?. PubMed. 5(2). 233–48. 1 indexed citations
3.
Crudden, Caitrin, Simin Zhang, Dawei Song, et al.. (2023). Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness. Molecular Cancer Research. 21(12). 1288–1302. 2 indexed citations
4.
Bebelman, Maarten P., Jeffrey R. van Senten, Caitrin Crudden, et al.. (2023). Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavenging. iScience. 26(8). 107412–107412. 7 indexed citations
5.
Song, Dawei, Caitrin Crudden, Eric Trocmé, et al.. (2021). IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma. Oncogene. 41(4). 600–611. 11 indexed citations
6.
Crudden, Caitrin, Dawei Song, Mihnea P. Dragomir, et al.. (2020). Inhibition of G Protein–Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth. Cancer Research. 81(2). 501–514. 18 indexed citations
7.
Bebelman, Maarten P., et al.. (2020). The forces driving cancer extracellular vesicle secretion. Neoplasia. 23(1). 149–157. 57 indexed citations
8.
Bebelman, Maarten P., Caitrin Crudden, D. Michiel Pegtel, & Martine J. Smit. (2020). The Convergence of Extracellular Vesicle and GPCR Biology. Trends in Pharmacological Sciences. 41(9). 627–640. 30 indexed citations
9.
Crudden, Caitrin, Dawei Song, Eric Trocmé, et al.. (2019). Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey. Cells. 8(10). 1223–1223. 34 indexed citations
10.
Lohcharoenkal, Warangkana, Lorenzo Pasquali, Caitrin Crudden, et al.. (2018). Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis. Journal of Investigative Dermatology. 138(4). 882–892. 36 indexed citations
11.
Crudden, Caitrin, et al.. (2018). Blurring Boundaries: Receptor Tyrosine Kinases as functional G Protein-Coupled Receptors. International review of cell and molecular biology. 339. 1–40. 32 indexed citations
12.
Crudden, Caitrin, Claire Worrall, Iulian I. Oprea, et al.. (2017). Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes. Oncogene. 36(41). 5734–5744. 28 indexed citations
13.
Worrall, Claire, et al.. (2017). Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma. Oncogene. 36(23). 3274–3286. 35 indexed citations
14.
Crudden, Caitrin, et al.. (2017). Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation. Oncotarget. 8(47). 82256–82267. 15 indexed citations
15.
Girnita, Leonard, Shin‐Ichiro Takahashi, Caitrin Crudden, et al.. (2016). Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling. Progress in molecular biology and translational science. 141. 277–311. 18 indexed citations
16.
Crudden, Caitrin, Ada Girnita, & Leonard Girnita. (2015). Targeting the IGF-1R: The Tale of the Tortoise and the Hare. Frontiers in Endocrinology. 6. 64–64. 63 indexed citations
17.
Crudden, Caitrin, et al.. (2014). The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?. Growth Hormone & IGF Research. 25(1). 2–12. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026